With the Tear Film And Ocular Surface Society’s Dry Eye Workshop update comes a more nuanced definition of dry eye disease.

The FDA has accepted for review the second resubmitted NDA for reproxalap for the treatment of the signs and symptoms of dry eye disease.

In this research topic we would like to address the question of what improvements are needed in the treatment of posterior eye disease. These improvements ...